Danaher Corporation $DHR Shares Sold by Cullen Frost Bankers Inc.

Cullen Frost Bankers Inc. cut its holdings in Danaher Corporation (NYSE:DHR) by 2.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 126,960 shares of the conglomerate’s stock after selling 3,154 shares during the period. Cullen Frost Bankers Inc.’s holdings in Danaher were worth $25,171,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. WFA of San Diego LLC purchased a new stake in Danaher during the second quarter worth approximately $26,000. Howard Hughes Medical Institute acquired a new stake in Danaher during the second quarter worth approximately $27,000. TruNorth Capital Management LLC acquired a new stake in Danaher during the third quarter worth approximately $28,000. Red Tortoise LLC lifted its position in shares of Danaher by 175.0% during the 2nd quarter. Red Tortoise LLC now owns 154 shares of the conglomerate’s stock worth $30,000 after buying an additional 98 shares during the last quarter. Finally, Tripletail Wealth Management LLC acquired a new position in shares of Danaher in the 3rd quarter valued at $31,000. 79.05% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on DHR shares. Wall Street Zen raised shares of Danaher from a “hold” rating to a “buy” rating in a research report on Saturday, November 22nd. Barclays boosted their target price on Danaher from $225.00 to $250.00 and gave the company an “overweight” rating in a report on Wednesday, October 22nd. JPMorgan Chase & Co. upped their target price on Danaher from $260.00 to $270.00 and gave the company an “overweight” rating in a research report on Wednesday, October 22nd. Jefferies Financial Group raised their price target on Danaher from $245.00 to $255.00 and gave the stock a “buy” rating in a research note on Wednesday, December 17th. Finally, Guggenheim boosted their price objective on Danaher from $250.00 to $275.00 and gave the company a “buy” rating in a research note on Friday, January 2nd. Twenty research analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, Danaher presently has an average rating of “Moderate Buy” and a consensus price target of $252.09.

Danaher Price Performance

Shares of NYSE DHR opened at $234.91 on Friday. The stock has a fifty day moving average price of $230.26 and a 200 day moving average price of $213.17. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $258.23. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The company has a market cap of $165.93 billion, a PE ratio of 48.43, a P/E/G ratio of 3.58 and a beta of 0.89.

Danaher Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Friday, January 30th. Stockholders of record on Friday, December 26th will be issued a $0.32 dividend. The ex-dividend date of this dividend is Friday, December 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.5%. Danaher’s payout ratio is presently 26.39%.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 21,776 shares of the stock in a transaction dated Wednesday, November 12th. The shares were sold at an average price of $219.23, for a total transaction of $4,773,952.48. Following the completion of the transaction, the senior vice president directly owned 14,553 shares of the company’s stock, valued at $3,190,454.19. This represents a 59.94% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, SVP Georgeann Couchara sold 5,174 shares of Danaher stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $210.42, for a total value of $1,088,713.08. Following the completion of the sale, the senior vice president directly owned 2,625 shares in the company, valued at $552,352.50. This represents a 66.34% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 30,248 shares of company stock worth $6,609,663 over the last ninety days. 11.10% of the stock is currently owned by company insiders.

Danaher Company Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.